ArticleJournal of clinical psychopharmacology

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.

Jose de Leon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.